HomeHEM • CVE
add
Hemostemix Inc
Previous close
$0.040
Day range
$0.040 - $0.045
Year range
$0.040 - $0.18
Market cap
3.91M CAD
Avg Volume
41.66K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 380.04K | -60.13% |
Net income | -257.24K | 68.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -379.98K | 60.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 377.59K | -62.68% |
Total assets | 701.15K | -40.11% |
Total liabilities | 7.55M | 48.49% |
Total equity | -6.85M | — |
Shares outstanding | 87.12M | — |
Price to book | -0.50 | — |
Return on assets | -188.84% | — |
Return on capital | 36.11% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -257.24K | 68.26% |
Cash from operations | -66.14K | 93.91% |
Cash from investing | — | — |
Cash from financing | 289.41K | -80.02% |
Net change in cash | 223.26K | -38.41% |
Free cash flow | -223.87K | 78.23% |
About
Headquarters
Website
Employees
9